Selecting the optimal oral antihistamine for patients with allergic rhinitis. Drugs 2006;66(18):2309-2319.
Clinical practice guidelines: allergic rhinitis executive summary. Otolaryngol Head Neck Surg 2015 Feb;152(2):197-200.
A study of allergen sensitivity in patients with allergic rhinitis in Bangalore, India. J Laryngol Otol 2014 Oct;128(10):892-896.
Available from https://www.nlm.nih.gov/medlineplus/ency/article/000813.htm.
Allergic rhinitis: a neglected disease – a community based assessment among adults in Delhi. J Postgrad Med 2015 Jul-Sep;61(3):169-175.
Patient information: allergic rhinitis (seasonal allergies) (Beyond the Basics) [cited 4 Jul 2016]. Available from: http://www.uptodate.com/contents/allergic-rhinitis-seasonal-allergies-beyond-the-basics.
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and Aller Gen). Allergy 2008 Apr;63(Suppl 86):8-160.
Treatment of allergic rhinitis. Am Fam Physician 2010 Jun;81(12):1440-1446.
International primary care respiratory group (IPCRG) guidelines: management of allergic rhinitis. Prim Care Respir J 2006 Feb;15(1):58-70.
British Society for Allergy and Clinical Immunology. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008 Jan;38(1):19-42.
Clinical practice. Allergic rhinitis. N Engl J Med 2005 Nov;353(18):1934-1944.
The diagnosis and management of rhinitis: an updated practice parameter [published correction appears in J Allergy Clin Immunol 2008 Dec;122(6):1237].
Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 Nov;108(Suppl 5):S147-S334.
Molecular and clinical pharmacology of intra-nasal corticosteroids: clinical and therapeutic implications. Allergy 2008;63(10):1292-1300.
Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomized controlled trials. BMJ 1998 Dec;317(7173):1624-1629.
Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002 Nov;89(5):479-484.
A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 1998 Aug;47(2):118-125.
Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity. J Allergy Clin Immunol 1998 Apr;101(4 Pt 1): 470-474.
Medium and long-term growth in children receiving intranasal beclomethasone dipropionate: a clinical experience. South Med J 2002 Mar;95(3):334-340.
A review of the preclinical and clinical data of newer intra-nasal steroids used in the treatment of allergic rhinitis. J Allergy Clin Immunol 1999 Oct;104(4 Pt 1):S150-S158.
Comparison of effects of fluticasone propionate nasal spray on day time alertness and performance in children with SAR. Ann Allergy Asthma Immunol 2004 Mar;92(3);344-349.
The pharmacology and biochemistry of histamine receptors; 1996. [cited 5 Jul 2016]. Available from: http://www.nottingham.ac.uk/~mqzwww/histamine.html.
Antihistamines and mast cell stabilizers. In: Mahmoudi M, editor. Allergy and asthma: practical diagnosis and management. Chapter 37, 2nd ed. Berlin: Springer; 2016. p. 571.
Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic. Ann Allergy Asthma Immunol 2004 Mar;92(3):294-303; quiz 303-305, 355.
A systematic review of epidemiological studies investigating risk factors for work-related road traffic crashes and injuries. Inj Prev 2008 Feb;14(1):51-58.
Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf 2000 Jul;23(1):11-33.
1 (ACT 1) Study Group. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clin Ther 2005 May;27(5):543-553.
Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann Allergy Asthma Immunol 2003 Aug;91(2):205-211.
New options in the management of asthma. The European Respiratory Society Congress; 1997 Sep 20-24; Berlin, Germany.
The role of leukotriene modifiers in the treatment of rhinitis. Western Society of Allergy and Immunology 36th annual scientific session; 1998 Jan 18-22; Maui, Hawaii.
Ten days’ use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. Arch Otolaryngol Head Neck Surg 1999 Oct;125(10):1128-1132.
Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989 Mar;83(3):627-633.
Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. Clin Exp Allergy 2006 May;36(5):676-684.
Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in monotherapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis [published correction appears in Clin Exp Allergy 2004 Aug;34(8):1329]. Clin Exp Allergy 2004 Feb;34(2):259-267.
Second-generation antihistamines in asthma therapy: is there a protective effect? Am J Respir Med 2002;1(1):27-34.
Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism. Eur Ann Allergy Clin Immunol 2004 Feb;36(2):67-70, 72.
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001 Sep;108(3):E48.
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a metaanalysis of randomized, doubleblind, placebo-controlled clinical trials. Int Arch Allergy Immunol 2011;156(1):1-15.
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol 2008 Nov;122(5):951-960.